Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/15/11 → 6/1/17 |
Funding
- Bristol Myers Squibb Company: $109,379.00
A Phase IIb, Randomized, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with BMS-936557 in Subjects with Active Ulcerative Colitis (UC)
- Flomenhoft, Deborah (PI)
- De Villiers, Willem (Former PI)